Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FKEMQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,074
Award facts
- Contract value 100% obligated
- $15,073.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,073.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 24, 2025. This firm fixed-price delivery order is for 240 units of Alecensa 150 mg capsules, an oncology medication used in cancer treatment. The contract contains no set-aside designation and is scheduled for ultimate completion by October 16, 2025, with performance taking place at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026. Through this broader contract vehicle, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products to military and federal healthcare facilities nationwide, including branded and generic prescription drugs, biologics, vaccinations, and specialty medications. The company's established role as a critical supplier in the federal pharmaceutical supply chain enables DLA to efficiently procure specialized medications such as Alecensa directly to support Department of Defense healthcare sites worldwide.
Quick answers
Who was awarded contract SPE2DB25FKEMQ?
SPE2DB25FKEMQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FKEMQ worth?
The government has obligated $15,074 on SPE2DB25FKEMQ.
Is contract SPE2DB25FKEMQ an order under another contract?
Yes. SPE2DB25FKEMQ is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEMQ competed?
The extent of competition for SPE2DB25FKEMQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award